|
US2005059110A1
|
|
Human nervous system-associated proteins
|
|
AU2003212475A1
|
|
Immune response associated proteins
|
|
WO03061601A2
|
|
Aminophospholipid transporter atpase
|
|
US2003138835A1
|
|
Tumor suppressors
|
|
AU2003205230A1
|
|
Digenic mutations associated with severe insulin resistance and type 2 diabetes and their use in the diagnosis and treatment of diabetes
|
|
WO03062379A2
|
|
Molecules for disease detection and treatment
|
|
AU2003217223A8
|
|
Metalloproteins
|
|
WO03062376A2
|
|
Molecules for diagnostics and therapeutics
|
|
US2003124609A1
|
|
Ankyrin repeat domain 2 protein variant
|
|
CA2471376A1
|
|
Nucleotide polymorphisms associated with osteoporosis
|
|
AU2002366713A1
|
|
Nucleotide polymorphisms associated with osteoarthritis
|
|
WO03056027A1
|
|
Carbohydrate-associated proteins
|
|
EP1480994A1
|
|
Neurotransmission-associated proteins
|
|
AU2002357860A8
|
|
Enzymes
|
|
AU2002357147A1
|
|
Transporters and ion channels
|
|
AU2002360513A8
|
|
Kinases and phosphatases
|
|
EP1519741A2
|
|
Proteins associated with cells growth, differentiation and death
|
|
US2003100485A1
|
|
Human neurotrimin homolog
|
|
WO03047526A2
|
|
Cell adhesion and extracellular matrix proteins
|
|
WO03046151A2
|
|
Nucleic acid-associated proteins
|
